Syncope
140
21
24
80
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
16 trials with published results (11%)
Research Maturity
80 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.1%
3 terminated out of 140 trials
96.4%
+9.8% vs benchmark
3%
4 trials in Phase 3/4
20%
16 of 80 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 80 completed trials
Clinical Trials (140)
Practical Approaches to Care in Emergency Syncope
Ambulatory Leadless Electrocardiogram Recorder Trial Feasibility
Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways
7-Day MEMO Patch Monitoring for Arrhythmia Detection in Patients With Palpitations
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
Pediatric Adhesion and New Dermal Approach Study
The Effect of Water Carbonation on Orthostatic Tolerance
Using Mirabegron to Increase BP in Patients With POTS
In Hospital 24 Hour Observation of Syncope Patients
Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?
REmote Cardiac MOnitoring of At-risk SYNCope Patients After Emergency Department Discharge -RCT
Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Genetic Markers of Cardiovascular Disease in Epilepsy
Canadian Prehospital Syncope Risk Score (Prehospital CSRS)
AVEIR™ Leadless Pacemaker (LP) United Kingdom (UK) Registry
ISSUE3: International Study on Syncope of Uncertain Etiology 3
ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic Syncope
Efficacy of a Right-sided Ablation of the Anterior Ganglionated Plexus for Neurally Mediated Syncope